4 Results for "

multidrug-resistant variants

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "multidrug-resistant variants" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-128780B
CAS No.: 2408422-41-1
Purity:  99.74%
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

SPR206 acetate is a polymyxin analog with antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. SPR206 acetate has an anti-bacterial infection effect by interacting with the bacterium’s outer membrane. The MIC values of SPR206 acetate against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L .
loading...
    loading...
Cat. No.: HY-179220
CAS No.: 2459707-59-4
Target:  

HIV Protease HIV

Research Areas:  

Infection

HIV-1-IN-88 (compound 20a) is a potent HIV‑1 protease inhibitor (IC50 = 10 pM) with an antiviral EC50 of 10.4 nM. HIV-1-IN-88 exhibits potency against the multidrug-resistant variants HIV-1Muta and HIV-1I50V with EC50 values of 30.0 and 34.3 nM, respectively. HIV-1-IN-88 can be used for HIV research .
loading...
    loading...
Cat. No.: HY-179221
Target:  

HIV

Research Areas:  

Infection

HIV-1-IN-89 (Compound 20a-D) is a prodrug of 20a (an HIV-1 protease inhibitor). HIV-1-IN-89 has better pharmacokinetic properties. HIV-1-IN-89 can be used for studying the resistance to HIV-1 .
loading...
    loading...
Cat. No.: HY-181888
Target:  

HIV HIV Protease

Research Areas:  

Infection

GRL-142 is a potent HIV-1 protease inhibitor capable of crossing the blood-brain barrier. GRL-142 exhibits extremely high inhibitory activity against both wild-type and multidrug-resistant strains (IC50=0.0094 nM). GRL-142 acts synergistically with the P2/P2' segments via a unique scaffold binding mechanism, utilizes fluorine-mediated stable interactions to maintain its bioactive conformation, adapts to p51 HIV-1 protease mutants, and maintains the flap-closed state by directly acting on the flap tip residues. GRL-142 disrupts the flap-water hydrogen bond network of wild-type protease, thereby effectively blocking viral replication. GRL-142 can be used to study HIV-1 infection and the associated neurocognitive disorder (HAND) .
loading...
    loading...